Skip to main navigation Skip to search Skip to main content

Antiviral drugs and acute kidney injury (AKI)

  • Wattana Leowattana

Research output: Contribution to journalReview articlepeer-review

46 Citations (Scopus)

Abstract

The introduction of more efficient antiviral drugs are common cause drug-induced acute kidney injury (AKI). The true prevalence of antiviral drugs induced nephrotoxicity is hardly determined. It causes AKI by many mechanisms including acute tubular necrosis (ATN), allergic interstitial nephritis (AIN), and crystal nephropathy. ATN has been described with a few kinds of antiviral drugs such as cidofovir, adefovir and tenofovir with unique effects on transporter defects, apoptosis, and mitochondrial injury. AIN from atazanavir is a rapid onset of AKI and usually non-oliguric but dialytic therapy are needed because of severity. Additionally, crystal nephropathy from acyclovir, indinavir, and foscarnet can cause AKI due to intratubular obstruction. In this article, the mechanisms of antiviral drug-induced AKI were reviewed and strategies for preventing AKI were mentioned.

Original languageEnglish
Pages (from-to)375-382
Number of pages8
JournalInfectious Disorders - Drug Targets
Volume19
Issue number4
DOIs
Publication statusPublished - 2019

Keywords

  • Acute kidney injury (AKI)
  • Acyclovir
  • Adefovir
  • Antiviral drugs
  • Atazanavir
  • Cidofovir
  • Foscarnet
  • Indinavir
  • Tenofovir

Fingerprint

Dive into the research topics of 'Antiviral drugs and acute kidney injury (AKI)'. Together they form a unique fingerprint.

Cite this